Renal collapse: A window into an underlying high-grade hematological malignancy – A case report

Kidney disease is prevalent in patients with hematologic malignancies, particularly multiple myeloma (MM) and acute leukemias. These conditions can directly infiltrate the kidneys or disrupt renal function through metabolic and immunological mechanisms. Renal failure is a significant complication, often the second leading cause of mortality in MM patients. Over 50% of multiple myeloma patients experience renal impairment, commonly identified as "myeloma kidney." Occasionally, blastoid morphology of some plasma cells can lead to diagnostic confusion, necessitating the use of immunohistochemistry to distinguish plasma cell leukemia (PCL) from other types of leukemias and lymphomas. Accurate diagnosis of renal disease can also reveal underlying hematologic malignancies, as demonstrated in our case where a kidney biopsy diagnosed a high-grade malignancy, facilitating timely and correct management.

Authors

Publication Details

Journal
World Journal of Biology Pharmacy and Health Sciences
Published
2024-12-27
DOI
https://doi.org/10.30574/wjbphs.2024.20.3.1039
Primary Topic
Methemoglobinemia and Tumor Lysis Syndrome
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Renal collapse: A window into an underlying high-grade hematological malignancy – A case report

A C Patowary, Harpreet Singh, Pradeep Mahajan, Nidhi Anand et al.
World Journal of Biology Pharmacy and Health Sciences
Methemoglobinemia and Tumor Lysis Syndrome
article

Renal collapse: A window into an underlying high-grade hematological malignancy – A case report

A C Patowary, Harpreet Singh, Pradeep Mahajan, Nidhi Anand, Suresh Kumar
article en

Abstract

Kidney disease is prevalent in patients with hematologic malignancies, particularly multiple myeloma (MM) and acute leukemias. These conditions can directly infiltrate the kidneys or disrupt renal function through metabolic and immunological mechanisms. Renal failure is a significant complication, often the second leading cause of mortality in MM patients. Over 50% of multiple myeloma patients experience renal impairment, commonly identified as "myeloma kidney." Occasionally, blastoid morphology of some plasma cells can lead to diagnostic confusion, necessitating the use of immunohistochemistry to distinguish plasma cell leukemia (PCL) from other types of leukemias and lymphomas. Accurate diagnosis of renal disease can also reveal underlying hematologic malignancies, as demonstrated in our case where a kidney biopsy diagnosed a high-grade malignancy, facilitating timely and correct management.

World Journal of Biology Pharmacy and Health SciencesVol. 20(3)
Openalex Percentile: Top 56%
Methemoglobinemia and Tumor Lysis Syndrome
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.